TLX1/N fundamentals
An in-depth look to TELIX PHARMACEUTIC operating, investing, and financing activities
TLX1/N free cash flow for H2 24 is -205.94 M MXN. For 2024, TLX1/N free cash flow was 183.78 M MXN and operating cash flow was 555.03 M MXN.
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: MXN
Q1 '24
Q2 '24
Q3 '24
TTM